Ablynx Revenue and Competitors
Estimated Revenue & Valuation
- Ablynx's estimated annual revenue is currently $25.7M per year.
- Ablynx's estimated revenue per employee is $155,000
Employee Data
- Ablynx has 166 Employees.
- Ablynx grew their employee count by -33% last year.
Ablynx's People
| Name | Title | Email/Phone |
|---|
Ablynx Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $99.4M | 458 | 40% | N/A | N/A |
#2 | $20.6M | 133 | 22% | N/A | N/A |
#3 | $156.1M | 146 | -70% | $145M | N/A |
#4 | $3.5M | 45 | -25% | $150M | N/A |
#5 | $1.6M | 21 | 0% | $459.5M | N/A |
#6 | $67.3M | 310 | 16% | $180.7M | N/A |
#7 | $8.5M | 55 | -2% | N/A | N/A |
#8 | $256.3M | 1025 | 9% | $168.5M | N/A |
#9 | $2.8M | 18 | -33% | N/A | N/A |
#10 | $9.1M | 59 | -9% | N/A | N/A |
What Is Ablynx?
Ablynx, a Sanofi company, is engaged in the development of Nanobodies®, proprietary therapeutic proteins based on single-domain antibody fragments, which combine the advantages of conventional antibody drugs with some of the features of small-molecule drugs. Nanobodies have potential uses in the treatment of a range of serious and life-threatening human diseases. Ablynx advances a portfolio of Nanobody-based therapeutic programs in several major disease areas, including inflammation, haematology, immuno-oncology and oncology. The acquisition of Ablynx (June 2018) continues Sanofi's commitment to breakthrough innovation, focused on technologies addressing multiple disease targets with single multi-specific molecules. Sanofi is committed to accelerating Ablynx's Nanobody development programmes.
keywords:N/A
N/A
Total Funding
166
Number of Employees
$25.7M
Revenue (est)
-33%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Ablynx News
Micro Chemotherapy Market Size And Forecast | Amgen, Celgene, MagForce AG, Nanotherapeutics, Spectrum Pharmaceuticals, Ablynx, AMAG, CytImmune,...
Codiak BioSciences (NASDAQ:CDAK) & Ablynx (OTCMKTS:ABLYF) Financial Analysis. Posted by admin on Apr 18th, 2022. Share on Twitter Share on Facebook Share on...
Advanced & Targeted Drug Delivery Market Size, Scope And Forecast | Leading Players 3M Company, Abbott Laboratories, Ablynx NV, Aciont Inc.